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ABSTRACT  
The use of alternatives assessment to substitute hazardous chemicals with 
inherently safer options is gaining momentum worldwide as a legislative and corporate 
strategy to minimize consumer, occupational, and environmental risks. Engineered 
nanomaterials represent an interesting case for alternatives assessment approaches as they can 
be considered both emerging “chemicals” of concern, as well as potentially safer alternatives 
to hazardous chemicals. However, comparing the hazards of nanomaterials to traditional 
chemicals or to other nanomaterials is challenging and critical elements in chemical hazard 
and exposure assessment may have to be fundamentally altered to sufficiently address 
nanomaterials. The aim of this paper is to assess the overall applicability of alternatives 
assessment methods for nanomaterials and outline recommendations to enhance their use in 
this context. This paper focuses on the adaptability of existing hazard and exposure 
assessment approaches to engineered nanomaterials as well as strategies to design inherently 
safer nanomaterials. We argue that alternatives assessment for nanomaterials is complicated 
by the sheer number of nanomaterials possible. As a result, the inclusion of new data tools 
that can efficiently and effectively evaluate nanomaterials as substitutes are needed to 
strengthen the alternatives assessment process. However, we conclude that with additional 
tools to enhance traditional hazard and exposure assessment modules of alternatives 
assessment, such as the use of mechanistic toxicity screens and control banding tools, 
alternatives assessment can be adapted to evaluate engineered nanomaterials both as potential 
substitutes for chemicals of concern and to ensure safer nanomaterials are incorporated in the 
design of new products.  
Keywords: Alternatives assessment, Engineered nanomaterials, Hazard, Safety by design, 
Decision-making 
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INTRODUCTION 
There are increasing scientific, market and policy concerns about the human 
health and environmental impacts of toxic chemicals in industrial manufacturing processes 
and in everyday consumer products. In response, government and private sector chemicals 
management policies have sought to minimize the risk of harm primarily by controlling 
exposure to chemical toxicants. Over the last decade there has been growing pressure to 
reduce or eliminate risks associated with chemicals of high concern by requiring substitution 
with safer alternatives. Examples of this are the European Union’s chemical legislation 
REACH and state level regulation in the U.S. implemented in Washington, Maine and 
California, which require assessments of hazardous chemicals classified as “priority” or “very 
high concern” to identify safer and feasible chemical or process substitutes (Cowan et al. 
2014). Central to these regulatory programs and similar activities by leading corporations, 
including product manufacturers and retailers, is the use of alternatives assessment (Lavoie et 
al. 2010; NRC 2014). 
Alternatives assessment is a methodology for identifying, comparing and 
selecting safer alternatives to chemicals of concern, including those in materials, processes or 
technologies. A primary goal of an alternatives assessment is to reduce potential harm to 
humans and the environment by selecting a safer chemical to achieve a specific function for a 
given application (i.e., solvency, electrical conduction, tensile strength, etc.). Engineered 
nanomaterials can be considered both as emerging “chemicals” of concern, as well as 
potential substitutes for highly toxic “bulk” chemicals in specific applications. However, 
evaluating the hazards and potential exposures to these novel materials has proven 
challenging; nano-specific hazard and risk research have lagged and technical guidance on 
how to complete such assessments is only slowly being developed. Nonetheless, product 
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design and redesign decisions that may incorporate engineered nanomaterials are being made 
now. As such, regulators, companies, and other stakeholders need comprehensive yet 
efficient ways to evaluate hazards and potential exposures to nanomaterials in substitution 
decisions. As alternatives assessment compares potential chemical and design alternatives to 
a chemical of concern, the goal is not a detailed evaluation of safety but rather to characterize 
safer options and identify possible unintended risk trade-offs from a substitution decision. 
Alternatives assessment frameworks are designed to be generic and flexible (NRC 2014) and 
therefore should in theory be applicable to nanomaterials. Yet given the unique physical and 
chemical characteristics of nanomaterials, an evaluation of specific modules within existing 
alternatives assessment frameworks, especially those focused on hazard and exposure 
evaluation, is needed to ensure potential adverse effects associated with nanomaterials are 
appropriately considered.   
The aim of this paper is to assess the overall applicability of alternatives 
assessment for nanomaterials and outline recommendations to enhance the use of this 
methodology to ensure the safer consideration of nanomaterials in manufacturing processes 
and products. This paper first briefly reviews the scope of alternatives assessment 
frameworks and focuses on how such frameworks evaluate hazard, exposure and physical 
chemical characteristics – critical elements of an alternatives assessment that may differ 
between traditional bulk and engineered nanomaterials. We then address central questions 
relevant to the applicability of alternatives assessment in the evaluation of nanomaterials and 
analyze the feasibility of the hazard and exposure modules for nanomaterials as well as the 
use of alternative tools to address and reduce risk. Finally, we provide recommendations and 
suggest modifications to the existing alternatives assessment frameworks to better aid the 
selection of safer nanomaterials.  
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SCOPE OF ALTERNATIVES ASSESSMENT: THE IC2 AND NRC FRAMEWORKS 
Alternatives assessment involves: (a) identifying the chemical of concern; (b) 
identifying candidate alternatives that can achieve the same purpose or function served by the 
chemical of concern for a given application; (c) evaluating and comparing alternatives and 
the chemical of concern based on a range of human and environmental health endpoints at 
critical lifecycle points (e.g., manufacturing, use, disposal), as well as evaluating and 
comparing technical and economic feasibility characteristics; and (d) selecting the preferred 
feasible alternative that meets financial and technical requirements and minimizes health and 
environmental impacts (OECD, 2013; NRC, 2014; Jacobs et al. 2015). 
While over a dozen alternatives assessment frameworks have been published 
over the last decade by academic institutions, non-governmental and governmental 
organizations, we focus on two recently published frameworks: the Interstate Chemical 
Clearinghouse (IC2) “Alternatives Assessment Guide” and the National Research Council 
(NRC) “Framework to Guide Selection of Safer Chemicals” (IC2 2013; NRC 2014). These 
were chosen as they reflect the most current and the most comprehensive methodological 
frameworks for alternatives assessment. Figures 1 and 2 outline the scope of the IC2 and 
NRC frameworks, respectively.  
Both frameworks evaluate an array of similar endpoints to assess environmental 
and human health hazards, including carcinogenicity, reproductive and developmental 
toxicity, endocrine disruption, dermal and respiratory sensitization, mutagenicity, aquatic 
toxicity, among others. In total, the NRC framework outlines 14 human health hazard 
endpoints while the IC2 framework identifies a range of 6-18 endpoints. This range reflects 
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three levels of depth in the IC2 framework, from a quick scan using tools such Washington 
State’s “Quick Chemical Assessment Tool” to an “expanded” hazard assessment. Both 
frameworks depend on publicly available data to categorize hazards, including the United 
Nations Globally Harmonized System for the Classification and Labeling of Chemicals 
(GHS) and authoritative lists such as classification of carcinogens by the International 
Agency for Research on Cancer (IARC). The chemical of concern and the prospective 
alternatives are compared in each framework against a series of mammalian and ecotoxicity 
metrics for each of the endpoints addressed. To facilitate comparisons, both frameworks 
assign hazard classification levels using ranking 3-, 4-, or 5-point scales, (e.g., very high, 
high, moderate, low, very low). While both frameworks incorporate a range of traditional 
toxicological and in-silico approaches to evaluating hazard, the NRC framework specifically 
calls for greater use of high throughput data both in filling data gaps and eventually serving 
as primary hazard data.  
Exposure is addressed somewhat differently in the NRC and IC2 frameworks. 
The IC2 framework addresses exposure considerations only after the assessment of hazard, 
performance and cost in order to examine potential trade-offs with identified alternatives. The 
NRC framework considers factors that impact the “inherent exposure” of a chemical 
simultaneously along with ecological and human health hazards, i.e., the potential for reduced 
exposure due to inherent properties of the alternatives chemicals (as opposed to industrial 
hygiene techniques such as engineering controls or personal protective equipment). The NRC 
framework also considers routes of exposure and associated levels when integrating the 
evidence related to human and ecological toxicity among alternatives. In both frameworks, 
the result of the characterization of exposure is to identify relative differences in the exposure 
potential among alternatives, i.e., substantially equivalent, inherently preferable, or 
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potentially worse (higher levels of exposure). Thus the primary purpose of exposure 
evaluation is not to assist a quantification of the risks but rather to rank the alternatives and 
their exposure profiles from most to least desirable. Quantitative exposure assessment, as 
required in risk assessment, is included in the IC2 framework as “advanced” level where it is 
required, such as those assessments that are regulatory-based and dependent on risk 
characterization. 
It is important to note that the field of life cycle assessment is also 
demonstrating the applicability of its methods and tools for the evaluation of nanomaterial 
product alternatives as reviewed in a recent case study by Tsang and colleagues (2014). 
While the IC2 framework and the NRC framework both include components that address life 
cycle impacts, both defer to existing LCA methodologies when the evaluation of alternatives 
need to consider life cycle impacts beyond a robust evaluation human and environmental 
hazards and evaluation of intrinsic exposure concerns, including impacts such as global 
warming potential, acidification and eutrophication (IC2 2013; NRC 2014).   
 
IS NOVELTY OF NANOMATERIALS A BARRIER TO THEIR EVALUATION? 
As described above, the NRC and IC2 alternatives assessment frameworks 
require data on an array of attributes of potential alternatives in order to make decisions about 
which is safer. However, a key question affecting the applicability of alternatives assessment 
frameworks for their use in evaluating nanomaterials is the novelty of these materials.  
The UK Royal Commission on Environmental Pollution (RCEP) (2008) defines 
material novelty by distinguishing between four types of novel materials: (1) new materials 
hitherto unused or rarely used on an industrial scale, e.g., carbon nanotubes (CNTs); (2) new 
forms of existing materials with characteristics that differ significantly from familiar or 
  8 
naturally occurring forms, e.g., engineered gold nanoparticles; (3) new applications for 
existing materials or existing technological products formulated in a new way, e.g., cerium 
oxide nanoparticles used as a fuel additive; and (4) new pathways and destinations for 
familiar materials that may enter the environment in forms different from their manufacture 
and envisaged use (RCEP 2008). 
For new materials hitherto unused or rarely used on an industrial scale (RCEP 
category 1), alternatives assessment is an important tool to facilitate safer design. An example 
of hitherto unused nanomaterials is CNTs, first discovered in 1991. CNTs are high aspect 
ratio cylindrical nanostructures that can vary with regards to the number of carbon atoms 
layers and diameter (up to 20 nm), length (from a few micrometers up to millimeters) and 
surface functionalization. Due to variations in physico-chemical properties, the biological 
activity of CNTs vary as well (Donaldson et al. 2011). Some potential uses of CNTs are truly 
novel and exploit properties that are nano-related, such as their use in advanced memory 
devices. In these advanced products, nanomaterials may be far superior to conventional 
chemicals and materials from a performance perspective. Alternatives assessment in this 
context could be applied during the design-phase of research and development efforts to 
compare individual CNTs (different size, functionalization, shape, etc.,) or to select the safest 
CNT that also achieves the necessary function and performance. While alternatives 
assessments have routinely been employed reactively – identifying alternatives to chemical of 
concern – the approach is also useful to proactively design-out inherent hazards during the 
materials and product development stage.  
Nanoscale zero-valent iron (nZVI) is an example of a “new form of existing 
materials with characteristics that differ significantly from familiar or naturally occurring 
forms” (RCEP category 2). This is due to the significantly increased surface area that nZVI 
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obtains at the nanoscale, which leads to higher reactivity per mass unit compared to larger 
iron particles. TiO2 nanoparticles are an example of a nanomaterial that falls into the third 
RCEP category of novel categories as new applications of nanoscale TiO2 keep emerging, 
even though the use of TiO2 in itself is not new. RCEP category 4 include biodegradable 
polymeric particles such as poly(lactide-co-glycolides) (PLGA) as such polymer 
nanoparticles can be engineered to transgress biological membranes e.g., for use in drug 
delivery (Hansen et al. 2013). 
For all four types of novel materials, a fundamental question confronting the 
use of alternatives assessment for their evaluation is data availability. For any newly 
engineered chemical or material, there is a natural time course in generating data needed for 
conducting an alternatives assessment, most notably data on hazards and exposure. Lack of 
hazard data is a persistent challenge confronting hazard assessments, as complete hazard 
information on the broad range of potential health outcomes - even for chemicals that have 
been used for over a century - remains an issue. The characterization of exposure is also 
hindered by data gaps and detailed information about exposure significantly lags data on 
hazard – an issue plaguing nanomaterial risk characterization. 
However, given the relatively rapid timeframes by which decisions are being made on 
chemical substitution as well as design of new products that are incorporating nanomaterials, 
one defining feature of the alternatives assessment methodology is to make use of the entirety 
of the data, wherever it exists, for informed decision-making. While engineered 
nanomaterials are clearly novel, we have learned a lot about their properties and their novel 
characteristics. Despite lacking human and ecotoxicity endpoints for many nanomaterials, 
nanotoxicology has been an area of intensive research for over a decade. Given that data – 
albeit incomplete – are available for many nanomaterials, alternatives assessment methods 
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include techniques for making data gaps explicit and considered in the overall assessment, the 
novelty of nanomaterials in-and-of-itself is not sufficient to render alternatives assessment 
inapplicable for these materials. Quite the opposite: alternatives assessment of nanomaterials 
can help drive decisions down safer paths using whatever data is available for novel 
materials. 
 CHALLENGES TO EVALUATING ENGINEERED NANOMATERIALS 
Current hazard assessment methods 
Central to the evaluation of alternatives in both the IC2 and NRC frameworks is 
the assessment of hazard. Yet are these hazard assessment approaches appropriate for the 
evaluation of nanomaterials? The identity of a nanomaterial and variation within the same 
chemical form of a nanomaterial poses a challenge for alternatives assessment. Nanomaterials 
not only differ substantially compared to the bulk form of a given substance, but also within 
the same nanomaterial e.g., CNTs, TiO2 and Ag exist in numerous sizes, shapes, and 
configurations as nanoparticles. For example, multi-walled CNTs (MWCNTs) are emerging 
as potential alternatives for halogenated flame retardants. For a given alternatives assessment 
to identify safer alternatives to halogenated flame retardants, the question becomes, which 
MWCNT or which mixture of MWCNTs should be assessed, as there are tens of thousands of 
possible variations of MWCNTs. Alternatives assessment frameworks were originally 
developed to evaluate chemicals, not materials. In the case of chemicals, each is unique and 
can be identified through its unique Chemical Abstract Service (CAS) number. There is no 
analogous system to uniquely identify nanomaterials, or any material for that matter, as each 
differs based on specific physical and chemical characteristics, such as size, coating, surface 
charge, and surface chemistry. Due to lack of available data and lack of characterization of 
  11 
the particular nanoparticle studied in the available studies, hazard assessment of a specific 
particle becomes difficult, which was identified as a specific challenge in a recent 
comparative hazard assessment of nanosilver and bulk silver (Heine and Sass 2013). 
Alternatively, a hazard assessment based on data for particles of the same material (e.g., a 
hazard assessment for silver nanoparticles in general) will only give an overall description of, 
for instance, silver nanoparticles, without emphasis on the specific particle at hand, which 
fails to distinguish the differences in toxicity between similar particles with different 
properties. The issue becomes even further challenged by the fact that nanomaterials 
incorporated into commercial products are not always of the same level of purification as 
those required in research studies.  
Dose-metrics used to characterize hazards poses another challenge in the hazard 
assessment module for nanoparticles. For conventional chemicals, mass-based metrics (e.g., 
mg/kg) are used for assigning of concern-level cut-off values for many endpoints in existing 
hazards assessment tools. For many types of nanomaterials, dose-metrics based on specific 
surface area or particle number and/or size distribution/agglomeration state have been shown 
more relevant for pulmonary toxicity assessment (Oberdorster et al. 2007) as well as for 
ecotoxicity of SiO2 nanoparticles (Van Hoecke et al. 2009). However, for Ag, Cu, and Zn 
nanoparticles, ion release is a key factor for toxicity, whereas for other particles, like TiO2, 
the crystal structure may play a major role (Hartmann 2011). While this may seem to be a 
barrier to generalized rules of thumb to characterize hazards based on the properties of the 
nanoparticles, an understanding of which properties are related to hazard is beginning to 
emerge for different classes of nanomaterials.  
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Current exposure characterization and assessment methods 
As with hazard assessment, exposure assessment of nanomaterials is 
challenging as the behavior of these materials in the environment is dependent not only on 
the specific physicochemical properties of the material, but also on the environment into 
which the nanomaterials are released (Ganzleben and Hansen 2012; Hartmann et al. 2014). 
As noted by Ganzleben and Hansen (2012) it is often more important to understand the 
specific properties of nanomaterials released from diffuse and point sources after the 
nanomaterials has undergone initial transformation reactions, than it is to understand the 
specific properties of the pristine versions - but only rarely is such information available 
(Stone et al. 2010; Hartmann et al. 2014). Given the particular properties of nanomaterials, 
researchers have suggested that existing environmental fate and transport models used for 
chemicals are probably generally not applicable for these materials (Ganzleben and Hansen 
2012). As in the case of hazard identification, nanomaterials differ from most conventional 
dissolved chemicals, in the sense that the spatial distribution of mass concentration is likely 
not to be the most relevant parameter with which to describe the state of the environment 
(Quik et al. 2011; Ganzleben and Hansen 2012). Recently, a few models have been proposed 
for application to environmental exposure assessment of nanomaterials e.g., probabilistic 
mass flow analysis and kinetic modeling that do attempt to take agglomeration and 
sedimentation into account; validation of the models is difficult, however (Gottschalk et al. 
2013; Meesters et al. 2014). 
When it comes to occupational exposure, highly specialized research and 
measurement techniques are required in order to quantify the specific nanomaterial exposure 
due to mixture with other particle sources in the factory and the surrounding environment, as 
well as aerosol dynamics including agglomeration and deposition (Sipenbush, 2014; Liguori 
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et al. 2012). Thus far, researchers have focused on the development of number-based 
exposure metrics, using instrumentation that ranges from complex, difficult to use and 
expensive (e.g., scanning mobility particle sizers that measure particle number concentration 
as a function of particle size) to relatively simple and inexpensive (e.g., hand-held 
condensation particle counters that measure the total number of nanometer-sized particles). 
The use of the first category is likely to be limited to research, while the second category is a 
likely candidate for use in measuring against number-based occupational exposure limits. 
 
Using existing chemical modeling approaches of worker exposure is hampered 
by the fact that they very often rely on an occupational exposure limit or similar values 
having been established, which only exists for a few specific nanomaterials. Most exposure 
modeling tools furthermore use existing physico-chemical properties and do not consider 
nanospecific properties that have been noted as being important e.g., particle shape, surface 
area, surface energy, surface chemistry, state of dispersion and state of agglomeration (Aitken 
et al. 2011). 
 
OPPORTUNITIES AND RECOMMENDATIONS FOR THE USE OF 
ALTERNATIVES ASSESSMENTS OF ENGINEERED NANOMATERIALS  
A focus on functional use  
A fundamental question related to the scope of alternatives assessment is “why 
is the material/chemical present in the product?” What properties are needed, that an 
alternative material/chemical should also have in order to achieve the desired function and 
performance? The approach of focusing on function and broadly exploring alternatives to 
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meet that function, including considering the necessity of that function or performance has 
been termed “functional substitution” (Tickner et al. 2015). Perhaps surprisingly, this 
question of “why is the material present” can sometimes be difficult to answer for products 
containing nanomaterials, as some products merely utilize the nanomaterial for commercial 
purposes (e.g., a branding of a product). If such a nanomaterial serves no necessary function 
or is completely redundant and is potentially risky for human or environmental health, it may 
be easiest to simply avoid using that material.  
 
Identifying and designing safer nanomaterials 
As nanomaterials can be purposefully manipulated down to a single atom, one 
has the opportunity to modify a material to suit the needs of the market. Similarly, using 
emerging scientific knowledge about the properties, toxicity and exposure to nanomaterials, it 
may be possible to design safer nanomaterials. Therefore, a nanomaterial similar to the 
original but with specific modifications that reduce intrinsic hazard and exposure potential 
could very well prove to emerge from an alternatives assessment as the best alternative to the 
original. Morose (2010) described five principles of “Design for Safer Nanotechnology” that 
can direct efforts into reducing nanomaterial risk by modifying the nanomaterial or its use by 
the following principles as seen in Figure 3. 
Principle #5 “Reduce the quantity” will obviously reduce potential risks just as 
changing to a less toxic material (principle #2). Principle #5 is especially true for 
nanomaterials that are necessary to achieve an essential function. Thus, reducing risk to 
people and the environment depends on mitigating exposure potential. Principles #1, #3 and 
#4 all rely on modifying the nanomaterial to engineer a material that is inherently safer.  
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Designing safer nanomaterials incorporates occupational, consumer, and 
environmental considerations. Traditional risk reduction strategies, such as exposure controls 
for consumers may not necessarily also decrease the risk in an occupational setting or 
decrease the environmental impact of the material, as the exposure scenarios can be quite 
different. However, reducing the hazard of the material will benefit safety in any situation.  
 
Intrinsic hazard evaluation in alternatives assessment: learning from safer nanomaterial 
design  
The current state of nanosafety science is still not mature enough to accurately 
describe what parameters control toxicity of nanomaterials. This lack of mechanistic 
understanding is a major roadblock for the use qualitative or quantitative tools to estimate 
toxicity, such as structure activity relationships, modeling or read-across approaches. 
Nonetheless, general trends are emerging which could guide the selection of safer 
nanomaterials. For instance, in 2013 Burello and Worth published a rule for designing safer 
nanomaterials (Burello and Worth 2013). The rule is based upon earlier work on prediction of 
oxide nanoparticle toxicity (Burello and Worth 2011; Zhang et al. 2012) and relies on the 
calculation of energy band structures to assess the particle’s potential to induce oxidative 
stress by interfering with the cellular redox equilibrium. Since oxidative stress is a general 
mechanism of toxicity for a range of nanoparticles, they propose that generation of safer 
nanoparticles can be helped along through simple band energy calculations.  
To mitigate oxidative stress Burello and Worth suggest several strategies, 
including modifying the size of the particle to change the energy band structure or masking 
the reactivity with the use of coatings, such as SiO2 or surface functionalization (Burello and 
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Worth 2013). These are consistent with principle #1 and #3 of Morose’s (2010) SAFER 
principles (Figure 3). Gass et al. (2013) showed experimentally that SiO2 encapsulated 
nanoparticles (CeO2, ZnO, Fe2O3 and Ag) prove less toxic than their uncoated versions. 
Although some properties of the core material are left intact within the SiO2-shell (magnetic, 
plasmonic, phosphorescent or optical), other properties were also affected. For instance, the 
catalytic abilities of CeO2 disappeared after encapsulation as they rely on surface interactions. 
As for CeO2, the SiO2 encapsulation also removed the photocatalytic properties of ZnO, 
which is unwanted in cosmetics.  
Other studies on metal and metal oxide nanoparticles have revealed additional 
strategies to minimize toxicity. Ivask et al. (2013) conducted a review of the toxic action of 
Ag, ZnO and CuO nanoparticles and concluded that three factors are driving their toxicity: 
dissolution, cellular uptake and induction of oxidative stress. As the authors state, this 
knowledge can both aid the creation of particles that are “toxic by design” (e.g., Ag 
nanoparticle in medical dressings) as well as particles that are safer by design. For example, 
the rate of dissolution for ZnO nanoparticle can be controlled through Fe doping, which in 
turn does reduce ZnO toxicity (George et al. 2010). However, it should be noted that a 
reduced rate of dissolution could perhaps also be interpreted as an increased persistence of 
the nanoparticle and give rise to further dissemination in the environment. Similar doping 
approaches have also proven effective to reduce oxidative stress of TiO2 nanoparticles. For 
instance, Wake et al. (2004) showed how doping TiO2 nanoparticles with 1% (w/w) 
manganese reduced free radical generation by over 90 %, increased UVA absorption and 
introduced free radical scavenging behavior. 
To address cellular uptake of nanoparticles, size is clearly a paramount 
parameter (Oberdorster et al. 2007), and as Burello and Worth (Burello and Worth 2013) 
  17 
stated, also a way to address oxidative stress. Surface charge is unquestionably another key 
factor in understanding and controlling both nanoparticle uptake as well as toxicity (Harper et 
al. 2011; Fröhlich 2012). It is, however, important to emphasize that nanotoxicology and 
nanoparticle behavior remains complex and influenced by a multitude of other physico-
chemical properties, such as hydrophilicity, aggregation/agglomeration and shape. 
Ultimately, each of these parameters can potentially be optimized for both toxicity reduction 
and functionality.  
 Carbon nanomaterials are structurally quite diverse as well as unique among 
nanomaterials and certain design considerations are emerging to address safety. Yan et al. 
(2011) identified five ways to reduce the toxicity of carbon nanomaterials: (1) creating a 
more hydrophilic surface; (2) lowering the adsorbability; (3) changing the size; (4) using the 
less toxic double-walled carbon nanotubes instead of single-walled carbon nanotubes; and (5) 
modifying the surface charge to avoid aggregation/agglomeration. All of these green 
engineering strategies have been observed to lower the toxicity of carbon nanomaterials.  
For high aspect ratio nanomaterials (HARNs) like CNTs additional 
considerations have to be taken into account due to their resemblance to asbestos fibers. 
Donaldson et al. (2011) describes the so-called fiber pathogenicity paradigm “that dictate 
whether or not a fiber will be pathogenic when inhaled” depending on its width, length and 
biopersistence and concludes that their studies “point towards the likelihood that all HARNs 
will conform to the general fiber pathogenicity paradigm, although further research is 
needed” (Donaldson et al. 2011). The paradigm dictates that a production of safer HARNs 
means creating HARNs that are short, thick and/or biodegradable. The suggested cutoff size 
values for ‘safe’ HARNs are > 3µm in width and <5 µm in length (Donaldson et al. 2011).  
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 In addition to modifying existing nanomaterials, alternatives should also be 
sought among next generation nanomaterials that could outperform older generations, on both 
performance and safety. An example of this is cadmium-containing quantum dots, which 
likely will be replaced with less toxic materials such as luminescent carbon nanodots, 
graphene quantum dots, nanosized graphene or silicon quantum dots (Winnik and Maysinger 
2013). Another possibility is to use alternatives assessment as a tool to evaluate whole 
technologies, as it is not necessarily limited in scope to only address a chemical/material of 
concern in a commercial product (e.g., CNTs in tennis rackets) - environmental remediation 
with nZVI could also be the focus of an alternatives assessment. Here alternative treatment 
options can be compared, rather than finding an alternative to a single component in a 
remediation technology. 
The hunt for safer nanomaterials only seems to be intensifying as our 
understanding of nanotoxicology increases. In Europe multiple large international projects 
are currently working towards integrating safety consideration early into product design 
including Sanowork, GUIDEnano, NanoMile, and NanoReg. These projects generally have a 
strong focus on high-throughput testing and generating read-across principles for the safety 
assessment of nanomaterials. Though it is still too early to give specific advice on how this 
will feed into alternatives assessment, these research efforts will serve as critical sources of 
information on the future selection of safer nanomaterials.  
Alternatives assessment has the opportunity to advance the identification and 
ranking of safer nanomaterials through its comparative approach and by systematically 
evaluating what is known/unknown about human and ecologoical toxicological endpoints. 
There is a need to incorporate knowledge emerging from research on green and safer 
nanotechnology into alternative assessment frameworks as research is progressing rapidly to 
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understand the physico-chemical characteristics predictive of harm, which will ultimately 
guide engineering design principles for nanomaterials. This recommendation is consistent 
with the NRC’s own recommendations to enhance the use and evaluation of physicochemical 
properties in alternatives assessment in order “…to inform data gaps and guide the chemical 
design process.” This is also consistent with Hansen et al. (2013) use of physicochemical 
properties of nanomaterials as “early warning signs” of harm.  
While highly needed, the inclusion of a new suite of physiochemical properties 
relevant to factors that influence hazard characterization and environmental fate of 
nanomaterials such as those described above, e.g., size/shape, reactivity, and surface charge, 
is a complex task. A recent hazard assessment, which included nanosilver in the evaluation 
found that the research literature often failed to fully characterize the physicochemical 
characteristics of the study materials making such results unusable for subsequent hazard 
assessments (Heine and Sass 2013). Given the high diversity of nanomaterials, it cannot be 
expected that generic rules for “high,” “medium” or “low” hazard rankings based on specific 
physiochemical properties would hold true for all types of nanomaterials. Thus future 
research should take a case-study approach and evaluate a range of commonly used 
nanomaterials (e.g., Ag, TiO2, and CNTs) when undergoing method development.  
 
Intrinsic exposure evaluation of nanomaterials in alternatives assessment: learning from 
safer nanomaterials design  
The field of alternatives assessment has elevated the importance of selecting 
options that are less hazardous to human health or the environment based on the premise that 
minimizing hazard rather than exposure is the most effective strategy for preventing disease 
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and environmental damage (Jacobs et al. 2015). Yet it is rare for hazards to be completely 
eliminated and exposure mitigation should be considered, especially those factors that can 
reduce the intrinsic exposure potential of a given nanomaterial as exposure in many situations 
can be the easiest parameter to address. Also, consideration of intrinsic exposure is critical to 
understanding potential risk trade-offs that might occur between substitution options. Rather 
than complex exposure modeling, which is often required in risk assessment, simplified 
exposure estimates can likely meet the needs of most alternatives assessments where the core 
question to be answered is, “which chemical/material is safer”. 
Morose’s (2010) safer nanomaterial design principles incorporate several 
attributes that are relevant to the evaluation of intrinsic exposure in alternatives assessment. 
These include principle #4 “encapsulation” and principle #5 “reduce the quantity”. These 
concepts are already addressed in existing alternatives assessment frameworks. Both the NRC 
and IC2 frameworks include “quantity used” as a key metric in the evaluation of exposure. 
Similarly, both frameworks also include a number of physicochemical and/or processing and 
handling characteristics that influence the intrinsic exposure of a given chemical or 
nanomaterial, such as “binding strength/migration potential,” “processing characteristics” and 
“particle size”. Unlike the issue of intrinsic hazard evaluation where new evaluation tools are 
needed that link specific physicochemical characteristics of nanomaterials to varying hazard 
levels, existing approaches to consider intrinsic exposure in the NRC and IC2 frameworks 
may be sufficiently applicable for nanomaterials.  
However, alternatives assessment methods for the evaluation of intrinsic 
exposure of nanomaterials could benefit from recent developments. A range of control 
banding tools has been developed as alternative approaches for risk management and these 
could be integrated into alternatives assessment where more detailed exposure 
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characterization is needed, such as in the context of regulatory requirements under REACH 
or California’s Safer Consumer Products regulation. When there is a lack of quantitative 
exposure estimations, control banding provides a generic pragmatic approach to risk 
management by proposing a range of control measures (such as general ventilation, 
containment, etc.) according to the estimated range of “bands” of hazard and the range of 
“bands” of exposure” (ISO 2014). A number of control banding-type tools have already been 
developed for nanomaterials and they vary extensively in regard to scope and of domain of 
application, their types of algorithms, the extent to which, they rely on nanospecific 
information and finally, in their ranges and relative dynamics in protection (Liguori et al. 
2012). The most simple exposure assessment tools categorize exposure potential into “High”, 
“Medium” and “Low” based on the location of the nanoparticles in the process or products. 
For instance, in the framework known as NanoRiskCat developed by Hansen et al. (2014), 
the exposure potential is assumed to be high if the nanoparticles are airborne or suspended in 
liquids and considered to be medium and low, if the nanoparticles are surface bound and 
suspended in solids, respectively. Such a simple categorization employs knowledge about use 
characteristics as well as physicochemical characteristics and can be used to direct focus 
towards “designing exposure out” of the process and/or product (see Figure 4), which is 
consistent with Morose’s (2010) SAFER principle #4 “encapsulation”.  
For the most sophisticated control banding tools such as NanoSafer (Jensen et 
al. 2013) and Stoffenmanager Nano (Duuren-Stuurman et al. 2012) the allocation of exposure 
bands takes a wide range of parameters into account such as the respirable rotating drum 
dustiness index; the activity handling energy factor; the total mass of material handled in each 
work cycle; the duration of work cycle; the pause between work cycles; the number of work 
cycles per day; the amount of nanomaterial handled in each transfer (spoon, bag, big-bag 
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etc.); the time required for each transfer (spoon, bag, big-bag etc.); the volume of the work 
room; and the air-exchange rate (Liguori et al. 2012). 
 
In the IC2 alternatives assessment framework evaluated here as well as in many 
other available frameworks, the hazard module is followed by the exposure module. This 
ordering reflects an explicit decision-rule that exposures are likely to remain similar among 
alternatives for a particular function and application and that only those alternatives that 
demonstrate improved environmental and health attributes (i.e., hazard profiles) are 
evaluated, where necessary, with regard to exposure and other considerations such as cost. 
Interestingly, experts have recognized that hazard assessment will remain a significant 
challenge for many years to come when it comes to nanomaterials. For instance SCENIHR 
(2007) suggested that more emphasis should be placed on exposure characterization early in 
the assessment process. SCENIHR (2007) proposed a four-stage process which first focuses 
on identifying whether the manufacture, use and/or end of use disposal or recycling could 
result in exposure of humans or environmental species and ecosystems. This is followed by a 
characterization of the nature, level and duration of any exposure and then subsequently by 
an identification of the hazardous properties of any forms of the nanomaterial to which 
significant exposure is likely. While this approach was envisioned for use within the 
conventions of risk assessment, it could be adapted for alternatives assessment whereby a 
qualitative characterization of exposure potential is employed to interpret the hazard 
assessment findings. This is consistent with the NRC framework where inherent exposure 
potential (regardless of controls) is compared between options. An option with significantly 
lower exposure potential may, in some cases, be considered a safer alternative, even if a 
comprehensive hazard data set is not available. 
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Making decisions about nano-enabled alternatives 
As stated earlier, alternatives assessment is not simply a comparative evaluation of hazard 
and exposure characteristics of the alternatives.  Technical and economic feasibility as well as 
additional life cycle impacts are also examined and compared. However, alternatives 
assessment is not just a technical evaluation of these multiple attributes, it is directly tied to 
making a decision about a safer chemical, material or technology in either a design or 
substitution context. 
Malloy and colleagues (2013) have comprehensively reviewed how various decision 
approaches (e.g., decision rules and logic) and decision tools (e.g., multi-criteria decision 
analysis or MCDA) are used in alternatives assessment to assist with decision-making. When 
a range of attributes with very heterogeneous data and information is being assessed, more 
formal decision analysis tools such as MCDA can be useful. Recent case studies, including 
assessments of alternatives that have considered nanomaterials have demonstrated the utility 
of using MCDA to aid decision-making (Malloy et al 2013; Tsang et al 2014; Linkov et al. 
2007). MCDA involves applying decision criteria and weights to attributes that reflect 
stakeholder and decision-maker values that are inherent in the decision process. MCDA 
allows for the visualization and quantification of the tradeoffs involved to help support the 
decision-making process. MCDA has the advantage over less-structured decision-making 
methods due to its transparent methodology for combining heterogeneous data from disparate 
sources for and quantifying technical judgment and values and has been elevated as an 
important tool for nano-risk management (Linkow et al 2009; Fadel et al 2015). However, as 
noted by Hansen (2010) key issues in MCDA include who defines the decision criteria and 
how they are weighted and translated into numerical scores.  
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As we have showed in our analysis, several obstacles have to be overcome to 
facilitate decision-making about nano-enabled alternatives which are not present for 
chemicals. We therefore encourage the further development and incorporation of specialized 
tools into alternatives assessments, as well as case studies to explore their use when 
traditional methods are inadequate.  
CONCLUSION 
Alternatives assessment is a versatile and powerful tool for the comparative 
analysis of chemicals in order to identify safer options. The future design of products 
incorporating safer nanomaterials and the redesign of existing products with an emphasis on 
reducing the potential hazards for human health and the environment is key to the success of 
the innovations made possible through nanotechnology. In this paper, we have argued that the 
overall alternatives assessment approach, as evaluated based on the IC2 and NRC 
frameworks, is appropriate for nanomaterials. Yet some adaptations are needed as 
nanomaterials pose several methodological challenges.  
First, alternatives assessment for nanomaterials is complicated by the sheer 
number of nanomaterials possible. This puts a demand on specific characterization of the 
materials in question and new, hitherto not included, characteristics are needed to strengthen 
the scientific foundations of specific alternatives assessment modules. While the links 
between physicochemical properties and hazards still remain to be explored for most 
nanomaterials, toxicity studies are presently available and can be used in alternatives 
assessment frameworks. For the time being alternatives assessments on nanomaterials should 
primarily be based on results of actual toxicity tests (including high throughput testing) rather 
than hazard extrapolations from inherent physico-chemical properties.  
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Second, nanomaterials clearly demonstrate the need for alternatives assessment 
methods to consider the intrinsic exposure potential as part of the comparative assessment 
process as there are distinct physicochemical properties as well as use characteristics that will 
distinguish which alternative (nano or bulk chemical) is fundamentally safer. The NRC and 
IC2 frameworks already include intrinsic exposure metrics that are sufficiently applicable for 
nanomaterials although new approaches from control banding tools developed for 
nanomaterials could be considered.  
Third, the normal alternatives assessment hazard assessment module would 
likely fail to differentiate between different alternatives incorporating nanomaterials, since it 
may not adequately account for the differences in toxicity among similar materials 
with slightly different properties. However, in many cases it might be possible to make a 
generalized hazard assessment of the original nanomaterial of concern to identify endpoints 
of concern. The most effective path forward in the case of insufficient data might then be to 
compare the original nanomaterial with the identified alternatives with respect to the 
endpoint(s) of concern, with high throughput screening used to validate an alternative with 
reduced toxicity. If one alternative is not just a modified version of the original - a new 
generalized hazard assessment would have to be made to identify if that material is known to 
affect other endpoints. This does not, of course, ensure that no risk is present (not the 
objective of alternatives assessment) or that another, unknown, endpoint is not a concern. It 
only says that the alternative would be better for the investigated endpoint.  
In nanotoxicology, how results of high throughput toxicity testing feed into risk 
assessment is still being debated – but perhaps high throughput data might feel much more at 
home for use in alternatives assessment as the decision-context is different. While traditional 
chemical risk assessment still is unfeasible for nanomaterials at large, alternatives assessment 
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could drive near-term decision-making about materials choices as well as incorporate 
mechanistic toxicity data to aid the selection of safer nanomaterials. However, any alternative 
assessment that considers nanomaterials should start like all others, first with considering the 
scope of the alternatives assessment and understanding the purpose of adding nanomaterials 
to serve the function at hand. Alternatives assessment aids in explicitly asking the question, 
“is this nanomaterial even needed”. We encourage case studies of alternatives assessments 
that evaluate nanomaterials in order to further develop the necessary methods and to identify 
additional methodological needs going forward. We may still not in a position to fully predict 
or explain nanotoxicity, but perhaps the time is ready for making better and safer choices. 
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Figure 1: The IC2 Alternatives Assessment Guidance (IC2 2013) 
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Figure 2: U.S. National Research Council (NRC) Alternatives Assessment Framework (NRC 
2014) 
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Figure 3: The 5 principles of design for safer nanotechnology (Morose 2010) 
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Figure 4: Changing the location of the nanomaterial in a given product or process will 
decrease the exposure potential. From left (high exposure) to right (low exposure): Airborne 
nanoparticles  nanoparticles suspended in liquids  surface bound nanoparticles  
nanostructured surface. 
